Governor Signed
Email me when HB 527 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 527. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
HB 527 defines key pharmacy‑related terms and requires PBMs to use and disclose maximum allowable costs only for drugs with approved therapeutic equivalents that are not obsolete. It forces PBMs to provide searchable electronic price lists, update them weekly, and give pharmacies a 21‑day window to appeal cost decisions, with a 14‑business‑day resolution deadline. Violations can trigger daily fines of up to $2,500 per violation, and the Insurance Department may issue implementing rules.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 527
3 free questions a day, no accountHistory
- Governor Signed
- House/ to Governor
- House/ received enrolled bill from Printing
- House/ enrolled bill to Printing
- Enrolled Bill Returned to House or Senate
- Draft of Enrolled Bill Prepared
- Bill Received from House for Enrolling
- House/ signed by Speaker/ sent for enrolling
- House/ received from Senate
- Senate/ to House
- Senate/ signed by President/ returned to House
- Senate/ received from House
The 12 most recent of 62 recorded actions.
Sponsors
- Katy Hall (R) · sponsor
- Hall, Katy
- Vickers, Evan J.
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 527 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 527 freeOr ask your AI assistant about HB 527 directly:
Add to Claude, ChatGPT or Cursor